|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.64 USD | -0.19% |
|
-5.02% | -4.09% |
| 17/04 | Sarepta Therapeutics Seen Benefiting From New Elevidys Study, Better US Uptake in Second Half of 2026 | MT |
| 16/04 | Roche Plans New Trial for Muscular Dystrophy Therapy to Seek EU Approval | DJ |
Main competitors
| Change | 5d. change | 1 months change | 3 months change | Varia. Jan 1. | 1-year change | 3-years change | 5-years change | 10-years change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | -0.19% | -5.02% | +23.67% | -5.28% | -4.09% | -65.20% | -83.87% | -71.08% | +38.06% | 217.12Cr | |
| +2.12% | -2.26% | +23.86% | +5.17% | +7.00% | -31.47% | -41.74% | -77.40% | -67.63% | 236.46Cr | |
| -1.17% | +0.60% | -6.80% | -1.36% | -7.31% | +9.98% | -19.78% | - | - | 35Cr | |
| -0.29% | 0.00% | +1.93% | -1.44% | -6.42% | -32.04% | - | - | - | 7.43Cr | |
| Average | +0.12% | -2.53% | +10.66% | -0.73% | -2.71% | -29.68% | -48.46% | -74.24% | -14.78% | 124.02Cr | |
| Weighted average by Cap. | +0.84% | -3.37% | +21.28% | +0.04% | +0.93% | -43.31% | -58.88% | -74.37% | -17.04% |
- Stock Market
- Equities
- SRPT Stock
- Sector Sarepta Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition